Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
The Journal of Headache and Pain
Published in: The Journal of Headache and Pain 1/2024

Open Access 01-12-2024 | Migraine | Review

Health equity, care access and quality in headache – part 1

Authors: Claudio Tana, Bianca Raffaelli, Marcio Nattan Portes Souza, Elena Ruiz de la Torre, Daniel Gams Massi, Najib Kisani, David García-Azorín, Marta Waliszewska-Prosół

Published in: The Journal of Headache and Pain | Issue 1/2024

Login to get access

Abstract

Current definitions of migraine that are based mainly on clinical characteristics do not account for other patient’s features such as those related to an impaired quality of life, due to loss of social life and productivity, and the differences related to the geographical distribution of the disease and cultural misconceptions which tend to underestimate migraine as a psychosocial rather than neurobiological disorder.
Global differences definition, care access, and health equity for headache disorders, especially migraine are reported in this paper from a collaborative group of the editorial board members of the Journal of Headache and Pain. Other components that affect patients with migraine, in addition to the impact promoted by the migraine symptoms such as stigma and social determinants, are also reported.
Literature
1.
No authors listed (2018) Headache classification Committee of the International Headache Society (IHS) the international classification of headache disorders, 3rd edition. Cephalalgia 38(1):1–211
2.
Sakai F, Igarashi H, Yokoyama M, Begasse de Dhaem O, Kato H, Azuma Y, Koh R, Phillips H, Singh N, Craven A, Dodick DW, Miyake H (2023) Diagnosis, knowledge, perception, and productivity impact of headache education and clinical evaluation program in the workplace at an information technology company of more than 70,000 employees. Cephalalgia 43(4):3331024231165682PubMedCrossRef
3.
Stovner LJ, Hagen K, Linde M, Steiner TJ (2022) The global prevalence of headache: an update, with analysis of the influences of methodological factors on prevalence estimates. J Headache Pain 23(1):34PubMedPubMedCentralCrossRef
4.
García-Azorín D, Santana-López L, Lozano-Alonso JE, Ordax-Díez A, González-Osorio Y, Rojo-Rello S, Eiros JM, Sánchez-Martínez J, Recio-García A, Sierra-Mencía Á, Sanz-Muñoz I, Guerrero-Peral ÁL (2023) InfluenCEF study: clinical phenotype and duration of headache attributed to influenza infection. Cephalalgia 43(11):3331024231212900PubMedCrossRef
5.
Ashina M, Katsarava Z, Do TP, Buse DC, Pozo-Rosich P, Özge A, Krymchantowski AV, Lebedeva ER, Ravishankar K, Yu S, Sacco S, Ashina S, Younis S, Steiner TJ, Lipton RB (2021) Migraine: epidemiology and systems of care. Lancet 397(10283):1485–1495PubMedCrossRef
6.
GBD 2016 Headache Collaborators (2018) Global, regional, and national burden of migraine and tension-type headache, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 17(11):954–976CrossRef
7.
Manandhar K, Risal A, Steiner TJ, Holen A, Linde M (2015) The prevalence of primary headache disorders in Nepal: a nationwide populationbased study. J Headache Pain 16:95PubMedPubMedCentralCrossRef
8.
Ravishankar K (2003) Migraine management in developing countries: barriers to care—a headache clinic study from India. Cephalalgia 23:577
9.
Liu R, Yu S, He M, Zhao G, Yang X, Qiao X, Feng J, Fang Y, Cao X, Steiner TJ (2013) Health-care utilization for primary headache disorders in China: a population-based door-to-door survey. J Headache Pain 14(1):47PubMedPubMedCentralCrossRef
10.
Linde M, Gustavsson A, Stovner LJ, Steiner TJ, Barré J, Katsarava Z, Lainez JM, Lampl C, Lantéri-Minet M, Rastenyte D, Ruiz de la Torre E, Tassorelli C, Andrée C (2012) The cost of headache disorders in Europe: the Eurolight project. Eur J Neurol 19(5):703–711PubMedCrossRef
11.
Stokes M, Becker WJ, Lipton RB, Sullivan SD, Wilcox TK, Wells L, Manack A, Proskorovsky I, Gladstone J, Buse DC, Varon SF, Goadsby PJ, Blumenfeld AM (2011) Cost of health care among patients with chronic and episodic migraine in Canada and the USA: results from the international Burden of migraine study (IBMS). Headache 51(7):1058–1077PubMedCrossRef
12.
Bonafede M, Sapra S, Shah N, Tepper S, Cappell K, Desai P (2018) Direct and indirect healthcare resource utilization and costs among migraine patients in the United States. Headache 58:700–714PubMedCrossRef
13.
Waliszewska-Prosół M, Straburzyński M, Czapińska-Ciepiela EK, Nowaczewska M, Gryglas-Dworak A, Budrewicz S (2023) Migraine symptoms, healthcare resources utilization and disease burden in a large polish migraine cohort : results from 'Migraine in Poland'-a nationwide cross-sectional survey. J Headache Pain 24(1):40PubMedPubMedCentralCrossRef
14.
Ayzenberg I, Katsarava Z, Sborowski A, Chernysh M, Osipova V, Tabeeva G, Yakhno N, Steiner TJ, Lifting the Burden. (2012) The prevalence of primary headache disorders in Russia: a countrywide survey. Cephalalgia 32(5):373–381PubMedCrossRef
15.
Mbewe E, Zairemthiama P, Yeh H-H, Paul R, Birbeck GL, Steiner TJ (2015) The epidemiology of primary headache disorders in Zambia: a population-based door-to-door survey. J Headache Pain 16:515PubMed
16.
Yu S, Liu R, Zhao G, Yang X, Qiao X, Feng J, Fang Y, Cao X, He M, Steiner T (2012) The prevalence and burden of primary headaches in China: a population-based door-to-door survey. Headache 52(4):582–591PubMedCrossRef
17.
Linde M, Steiner TJ, Chisholm D (2015) Cost-effectiveness analysis of interventions for migraine in four low and middle-income countries. J Headache Pain 16:15PubMedPubMedCentralCrossRef
18.
Tana C, Azorin DG, Cinetto F, Mantini C, Tana M, Caulo M, Ricci F, Martelletti P, Cipollone F, Giamberardino MA (2023) Common clinical and molecular pathways between migraine and sarcoidosis. Int J Mol Sci 24(9):8304PubMedPubMedCentralCrossRef
19.
Tana C, Bentivegna E, Cho SJ, Harriott AM, García-Azorín D, Labastida-Ramirez A, Ornello R, Raffaelli B, Beltrán ER, Ruscheweyh R, Martelletti P (2022) Long COVID headache. J Headache Pain 23(1):93PubMedPubMedCentralCrossRef
20.
Affaitati G, Costantini R, Tana C, Cipollone F, Giamberardino MA (2020) Co-occurrence of pain syndromes. J Neural Transm (Vienna) 127(4):625–646PubMedCrossRef
21.
Gong Q, Liu S, Li R, Yao L, Xiao Z (2021) Overall trend towards headache remission during the COVID-19 pandemic among Chinese patients with pre-existing headache highlights the role of family support. BMC Neurol 21(1):224PubMedPubMedCentralCrossRef
22.
Polverino F, Stern DA, Ruocco G, Balestro E, Bassetti M, Candelli M, Cirillo B, Contoli M, Corsico A, D'Amico F, D'Elia E, Falco G, Gasparini S, Guerra S, Harari S, Kraft M, Mennella L, Papi A, Parrella R, Pelosi P, Poletti V, Polverino M, Tana C, Terribile R, Woods JC, Di Marco F, Martinez FD, ItaliCO study group (2020) Comorbidities, Cardiovascular Therapies, and COVID-19 Mortality: A Nationwide, Italian Observational Study (ItaliCO). Front Cardiovasc Med 7:585866PubMedPubMedCentralCrossRef
23.
Ebbesen BD, Giordano R, Valera-Calero JA, Hedegaard JN, Fernández-de-Las-Peñas C, Arendt-Nielsen L (2023) Prevalence and risk factors of de novo widespread post-COVID pain in non-hospitalized COVID-19 survivors: a nation-wide exploratory population-based survey. J Pain S1526-5900(23):00512–00516
24.
Tana C, Giamberardino MA, Martelletti P (2023) Long COVID and especially headache syndromes. Curr Opin Neurol 36(3):168–174PubMedCrossRef
25.
Krymchantowski AV, Silva-Néto RP, Jevoux C, Krymchantowski AG (2022) Indomethacin for refractory COVID or post-COVID headache: a retrospective study. Acta Neurol Belg 122(2):465–469PubMedCrossRef
26.
Gonzalez-Martinez A, Guerrero-Peral ÁL, Arias-Rivas S, Silva L, Sierra Á, Gago-Veiga AB, García-Azorín D (2022) Amitriptyline for post-COVID headache: effectiveness, tolerability, and response predictors. J Neurol 269(11):5702–5709PubMedPubMedCentralCrossRef
27.
Vinyes D, Muñoz-Sellart M, Caballero TG (2022) Local anesthetics as a therapeutic tool for post COVID-19 patients: a case report. Medicine (Baltimore) 101(28):e29358PubMedCrossRef
28.
Tana C, Cipollone F, Giamberardino MA (2023) New therapeutic options for migraine. Curr Pharm Des 29(25):1964–1966PubMedCrossRef
29.
Tana C, Cipollone F, Giamberardino MA, Martelletti P (2023) New drugs targeting calcitonin gene-related peptide for the management of migraines. Expert Opin Emerg Drugs 28(4):233–240.
30.
Takizawa T, Ihara K, Uno S, Ohtani S, Watanabe N, Imai N, Nakahara J, Hori S, Garcia-Azorin D, Martelletti P (2023) Metabolic and toxicological considerations regarding CGRP mAbs and CGRP antagonists to treat migraine in COVID-19 patients: a narrative review. Expert Opin Drug Metab Toxicol 5:1–17
31.
Rist PM, Buring JE, Manson JE, Sesso HD, Kurth T (2023) History of migraine and risk of COVID-19: a cohort study. Am J Med 136(11):1094–1098PubMedCrossRef
32.
Straburzyński M, Kuca-Warnawin E, Waliszewska-Prosół M (2023) COVID-19-related headache and innate immune response - a narrative review. Neurol Neurochir Pol 57(1):43–52PubMedCrossRef
33.
Aparisi Á, Ybarra-Falcón C, Iglesias-Echeverría C, García-Gómez M, Marcos-Mangas M, Valle-Peñacoba G, Carrasco-Moraleja M, Fernández-de-Las-Peñas C, Guerrero ÁL, García-Azorín D (2022) Cardio-pulmonary dysfunction evaluation in patients with persistent post-COVID-19 headache. Int J Environ Res Public Health 19(7):3961PubMedPubMedCentralCrossRef
34.
Ticinesi A, Nouvenne A, Tana C, Prati B, Meschi T (2019) Gut microbiota and microbiota-related metabolites as possible biomarkers of cognitive aging. Adv Exp Med Biol 1178:129–154PubMedCrossRef
35.
Ticinesi A, Tana C, Nouvenne A, Prati B, Lauretani F, Meschi T (2018) Gut microbiota, cognitive frailty and dementia in older individuals: a systematic review. Clin Interv Aging 13:1497–1511PubMedPubMedCentralCrossRef
36.
Ticinesi A, Nouvenne A, Tana C, Prati B, Cerundolo N, Miraglia C, De' Angelis GL, Di Mario F, Meschi T (2018) The impact of intestinal microbiota on bio-medical research: definitions, techniques and physiology of a "new frontier". Acta Biomed 89(9-S):52–59PubMed
37.
Bicknell B, Liebert A, Borody T, Herkes G, McLachlan C, Kiat H (2023) Neurodegenerative and neurodevelopmental diseases and the gut-brain Axis: the potential of therapeutic targeting of the microbiome. Int J Mol Sci 24(11):9577PubMedPubMedCentralCrossRef
38.
Di Lauro M, Guerriero C, Cornali K, Albanese M, Costacurta M, Mercuri NB, Di Daniele N, Noce A (2023) Linking migraine to gut Dysbiosis and chronic non-communicable diseases. Nutrients 15(20):4327PubMedPubMedCentralCrossRef
39.
Ticinesi A, Tana C, Nouvenne A (2019) The intestinal microbiome and its relevance for functionality in older persons. Curr Opin Clin Nutr Metab Care 22(1):4–12PubMedCrossRef
40.
Ticinesi A, Lauretani F, Tana C, Nouvenne A, Ridolo E, Meschi T (2019) Exercise and immune system as modulators of intestinal microbiome: implications for the gut-muscle axis hypothesis. Exerc Immunol Rev 25:84–95PubMed
41.
42.
Meo SA, Bukhari IA, Akram J, Meo AS, Klonoff DC (2021) COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna vaccines. Eur Rev Med Pharmacol Sci 25(3):1663–1669PubMed
43.
Castaldo M, Waliszewska-Prosół M, Koutsokera M et al (2022) Headache onset after vaccination against SARS-CoV-2: a systematic literature review and meta-analysis. J Headache Pain 23(1):41PubMedPubMedCentralCrossRef
44.
Sekiguchi K, Watanabe N, Miyazaki N, Ishizuchi K, Iba C, Tagashira Y, Uno S, Shibata M, Hasegawa N, Takemura R, Nakahara J, Takizawa T (2022) Incidence of headache after COVID-19 vaccination in patients with history of headache: a cross-sectional study. Cephalalgia 42(3):266–272PubMedCrossRef
45.
Silvestro M, Tessitore A, Orologio I, Sozio P, Napolitano G, Siciliano M, Tedeschi G, Russo A (2021) Headache worsening after COVID-19 vaccination: an online questionnaire-based study on 841 patients with migraine. J Clin Med 10:5914PubMedPubMedCentralCrossRef
46.
Brandt RB, Ouwehand RH, Ferrari MD, Haan J, Fronczek R (2022) COVID-19 vaccination-triggered cluster headache episodes with frequent attacks. Cephalalgia 42(13):1420–1424PubMedPubMedCentralCrossRef
47.
Chen SP, Takizawa T, Sekiguchi K, Nakahara J, Wang SJ (2023) COVID-19 vaccination elicited de novo and recurrence of cluster headache: a case series. Cephalalgia 43(5):3331024231173354PubMedCrossRef
48.
Suwanwela NC, Kijpaisalratana N, Tepmongkol S, Rattanawong W, Vorasayan P, Charnnarong C, Tantivattana J, Roongruang S, Ongphichetmetha T, Panjasriprakarn P, Chutinet A, Akarathanawat W, Saver JL (2022) Prolonged migraine aura resembling ischemic stroke following CoronaVac vaccination: an extended case series. J Headache Pain 23(1):13PubMedPubMedCentralCrossRef
49.
Waliszewska-Prosół M, Budrewicz S (2021) The unusual course of a migraine attack during COVID-19 infection - case studies of three patients. J Infect Public Health 14(7):903–905PubMedPubMedCentralCrossRef
50.
González-Celestino A, González-Osorio Y, García-Iglesias C, Echavarría-Iñiguez A, Sierra-Mencía A, Recio-García A, Trigo-López J, Planchuelo-Gómez A, Hurtado ML, Sierra-Martínez L, Ruiz M, Rojas-Hernández M, Pérez-Almendro C, Paniagua M, Núñez G, Mora M, Montilla C, Martínez-Badillo C, Lozano AG, Gil A, Cubero M, Cornejo A, Calcerrada I, Blanco M, Alberdí-Iglesias A, Fernández-de-Las-Peñas C, Guerrero-Peral AL, García-Azorín D (2023) Differences and similarities between COVID-19 related-headache and COVID-19 vaccine related-headache. A case-control study. Rev Neurol 77(10):229–239PubMed
51.
García-Azorín D, Do TP, Gantenbein AR, Hansen JM, Souza MNP, Obermann M, Pohl H, Schankin CJ, Schytz HW, Sinclair A, Schoonman GG, Kristoffersen ES (2021) Delayed headache after COVID-19 vaccination: a red flag for vaccine induced cerebral venous thrombosis. J Headache Pain 22(1):108PubMedPubMedCentralCrossRef
52.
Tana C, Moffa L, Falasca K, Vecchiet J, Tana M, Mantini C, Ricci F, Ticinesi A, Meschi T, Cipollone F, Giamberardino MA (2023) Approach to COVID-19 in older adults and indications for improving the outcomes. Ann Med 55(2):2265298PubMedPubMedCentralCrossRef
53.
54.
Sukocheva OA, Maksoud R, Beeraka NM, Madhunapantula SV, Sinelnikov M, Nikolenko VN, Neganova ME, Klochkov SG, Amjad Kamal M, Staines DR, Marshall-Gradisnik S (2022) Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome. J Adv Res 40:179–196PubMedCrossRef
55.
Rodrigues AN, Dias ARN, Paranhos ACM, Silva CC, Bastos TDR, de Brito BB, da Silva NM, de Sousa EJS, Quaresma JAS, Falcão LFM (2023 Mar) Headache in long COVID as disabling condition: a clinical approach. Front Neurol 23(14):1149294CrossRef
56.
Venkataramani V, Winkler F (2022) Cognitive deficits in long Covid-19. N Engl J Med 387(19):1813–1815PubMedCrossRef
57.
58.
Straburzynski M, Nowaczewska M, Budrewicz S, Waliszewska-Prosół M (2022) COVID-19-related headache and sinonasal inflammation: a longitudinal study analyzing the role of acute rhinosinusitis and ICHD-3 classification difficulties in SARS-CoV-2 infection. Cephalalgia 42(3):218–228PubMedCrossRef
59.
Dono F, Consoli S, Evangelista G, D'Apolito M, Russo M, Carrarini C et al (2021) New daily persistent headache after SARS-CoV-2 infection: a report of two cases. Neurol Sci 42(10):3965–3968PubMedPubMedCentralCrossRef
60.
Caronna E, Ballvé A, Llauradó A, Gallardo VJ, Ariton DM, Lallana S, López Maza S, Olivé Gadea M, Quibus L, Restrepo JL, Rodrigo-Gisbert M, Vilaseca A, Hernandez Gonzalez M, Martinez Gallo M, Alpuente A, Torres-Ferrus M, Pujol Borrell R, Alvarez-Sabin J, Pozo-Rosich P (2020) Headache: a striking prodromal and persistent symptom, predictive of COVID-19 clinical evolution. Cephalalgia 40(13):1410–1421PubMedPubMedCentralCrossRef
61.
Garcia-Azorin D, Layos-Romero A, Porta-Etessam J, Membrilla JA, Caronna E, Gonzalez-Martinez A, Mencia ÁS, Segura T, Gonzalez-García N, Díaz-de-Terán J, Gallardo VJ, Gago-Veiga AB, Ballvé A, Trigo López J, Sastre-Real M, Llauradó A, Cornejo A, de Lorenzo Í, Guerrero-Peral Á, Pozo-Rosich P (2022) Post-COVID-19 persistent headache: a multicentric 9-months follow-up study of 905 patients. Cephalagia 42(8):804–809CrossRef
62.
Raffaelli B, Kull P, Mecklenburg J, Overeem LH, Storch E, Terhart M, Neeb L, Reuter U (2021) Patients' and Health care Workers' perception of migraine images on the internet: cross-sectional survey study. J Med Internet Res 23(11):e32707PubMedPubMedCentralCrossRef
63.
Kempner J (2014) Not tonight: migraine and the politics of gender and health. The University of Chicago Press, ChicagoCrossRef
64.
65.
66.
67.
Schwedt TJ, Shapiro RE (2009) Funding of research on headache disorders by the National Institutes of Health. Headache: the journal of head and face. Pain 49(2):162–169
68.
Dodick DW, Loder EW, Manack Adams A, Buse DC, Fanning KM, Reed ML, Lipton RB (2016) Assessing barriers to chronic migraine consultation, diagnosis, and treatment: results from the chronic migraine epidemiology and outcomes (CaMEO) study. Headache 56(5):821–834PubMedPubMedCentralCrossRef
69.
70.
71.
Buse DC, Scher AI, Dodick DW, Reed ML, Fanning KM, Manack Adams A, Lipton RB (2016) Impact of migraine on the family: perspectives of people with migraine and their spouse/domestic partner in the CaMEO study. Mayo Clin Proc S0025-6196(16):00126–00129
72.
73.
74.
75.
76.
Befus DR, Irby MB, Coeytaux RR, Penzien DB (2018) A critical exploration of migraine as a Health disparity: the imperative of an equity-oriented, intersectional approach. Curr Pain Headache Rep 22(12):79PubMedCrossRef
77.
Braveman PA, Kumanyika S, Fielding J, Laveist T, Borrell LN, Manderscheid R, Troutman A (2011) Health disparities and health equity: the issue is justice. Am J Public Health 101(Suppl 1(Suppl 1):S149–S155PubMedPubMedCentralCrossRef
78.
79.
Smitherman TA, Ward TN (2011) Psychosocial factors of relevance to sex and gender studies in headache. Headache 51:923–931PubMedCrossRef
80.
Heise L, Greene ME, Opper N, Stavropoulou M, Harper C, Nascimento M, Zewdie D, Gender Equality, Norms, and Health Steering Committee (2019) Gender inequality and restrictive gender norms: framing the challenges to health. Lancet 393(10189):2440–2454PubMedCrossRef
81.
Burch R, Rizzoli P, Loder E (2018) The prevalence and impact of migraine and severe headache in the United States: figures and trends from government health studies. Headache 58(4):496–505PubMedCrossRef
82.
Loder S, Sheikh HU, Loder E (2015) The prevalence, burden, and treatment of severe, frequent, and migraine headaches in US minority populations: statistics from National Survey studies. Headache 55(2):214–228PubMedCrossRef
83.
Saadi A, Himmelstein DU, Woolhandler S et al (2017) Racial disparities in neurologic health care access and utilization in the United States. Neurology 88(24):2268–2275PubMedPubMedCentralCrossRef
84.
Yehia BR, Winegar A, Fogel R, Fakih M, Ottenbacher A, Jesser C, Bufalino A, Huang RH, Cacchione J (2020) Association of Race With Mortality Among Patients Hospitalized With Coronavirus Disease 2019 (COVID-19) at 92 US Hospitals. JAMA Network Open 3(8):e2018039
85.
Charleston L 4th (2021) Headache disparities in African-Americans in the United States: a narrative review. J Natl Med Assoc 113(2):223–229PubMed
86.
Onofri A, Pensato U, Rosignoli C et al (2023) Primary headache epidemiology in children and adolescents: a systematic review and meta-analysis. J Headache Pain 24(1):8PubMedPubMedCentralCrossRef
87.
Charleston L 4th, Royce J, Monteith TS, Broner SW, O'Brien HL, Manrriquez SL, Robbins MS (2018) Migraine care challenges and strategies in US uninsured and underinsured adults: a narrative review, part 1. Headache 58(4):506–511PubMedCrossRef
88.
Affatato O, Miguet M, Schiöth HB, Mwinyi J (2021) Major sex differences in migraine prevalence among occupational categories: a cross-sectional study using UK biobank. J Headache Pain 22(1):145PubMedPubMedCentralCrossRef
89.
Atasoy HT, Unal AE, Atasoy N, Emre U, Sumer M (2005) Low income and education levels may cause medication overuse and chronicity in migraine patients. Headache 45(1):25–31PubMedCrossRef
90.
91.
92.
Chalmer MA, Rasmussen AH (2021) International headache genetics consortium; 23andme research team; Kogelman LJA, Olesen J, Hansen TF. Chronic migraine: genetics or environment? Eur J Neurol 28(5):1726–1736PubMedPubMedCentralCrossRef
93.
Pearson C, Swindale R, Keighley P, McKinlay AR, Ridsdale L (2019) Not just a headache: qualitative study about web-based self-presentation and social media use by people with migraine. J Med Internet Res 21(6):e10479PubMedPubMedCentralCrossRef
94.
Cottrell C, Drew J, Waller S, Holroyd K, Brose J, O'Donnell F (2003) Perceptions and needs of patients with migraine: a focus group study. Headache 43(4):428–428CrossRef
95.
Rutberg S, Kerstin Ö (2012) Migraine--more than a headache: women's experiences of living with migraine. Disabil Rehabil 34(4):329–336PubMedCrossRef
96.
Battista S, Lazzaretti A, Coppola I, Falsiroli Maistrello L, Rania N, Testa M (2023) Living with migraine: a meta-synthesis of qualitative studies. Front Psychol 14:1129926PubMedPubMedCentralCrossRef
97.
Hamann T, Hong JB, Lange KS et al (2023) Perception of typical migraine images on the internet: comparison between a metropolis and a smaller rural city in Germany. PLoS One 18(8):e0290318PubMedPubMedCentralCrossRef
98.
García-Azorín D, Abelaira-Freire J, Rodriguez-Adrada E, González-García N, Guerrero ÁL, Porta-Etessam J, Martín-Sánchez FJ (2020) Study about the Manchester triage system subtriage in patients that visited the emergency department due to headache. Neurologia (Engl Ed) S0213-4853(20):30275–30279
99.
Lieba-Samal D, Platzer P, Seidel S, Klaschterka P, Knopf A, Wöber C (2011) Characteristics of acute posttraumatic headache following mild head injury. Cephalalgia 31(16):1618–1626PubMedCrossRef
100.
Ashina H, Dodick DW, Barber J, Temkin NR, Chong CD, Adler JS, Stein KS, Schwedt TJ, Manley GT, Investigators TRACK-TBI (2023) Prevalence of and risk factors for post-traumatic headache in civilian patients after mild traumatic brain injury: a TRACK-TBI study. Mayo Clin Proc S0025-6196(23):00113–00111
101.
Suwanwela N, Phanthumchinda K, Kaoropthum S (1994) Headache in brain tumor: a cross-sectional study. Headache 34(7):435–438PubMedCrossRef
102.
103.
van de Beek D, de Gans J, Spanjaard L, Weisfelt M, Reitsma JB, Vermeulen M (2004) Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med 351(18):1849–1859PubMedCrossRef
104.
Monto AS, Gravenstein S, Elliott M, Colopy M, Schweinle J (2000) Clinical signs and symptoms predicting influenza infection. Arch Intern Med 160(21):3243–3247PubMedCrossRef
105.
Acray-Zengbé P, Ano MN, Toure B, Kouassi PR, Ané AB, Akani C, Dagnan S (2020) Gratuité de la prise en charge du paludisme simple dans un hôpital général, Côte d’Ivoire, 2017. Sante Publique 32(4):419–429PubMedCrossRef
106.
Guo C, Zhou Z, Wen Z et al (2017) Global epidemiology of dengue outbreaks in 1990-2015: a systematic review and Meta-analysis. Front Cell Infect Microbiol 7:317PubMedPubMedCentralCrossRef
107.
108.
Evlice A, Genç H, Uluduz D, Baykan B, Bolay H, Unal-Cevik I, Kissani N, Luvsannorov O, Togha M, Ozge A, Head-MENAA study group (2023) Secondary headache disorders in Turkey, the Middle East, Asia, and Africa: a cross-sectional, multicenter study. Cephalalgia 43(8):3331024231194024PubMedCrossRef
109.
Munoz-Ceron J, Marin-Careaga V, Peña L, Mutis J, Ortiz G (2019) Headache at the emergency room: etiologies, diagnostic usefulness of the ICHD 3 criteria, red and green flags. PLoS One 14(1):e0208728PubMedPubMedCentralCrossRef
110.
García-Azorín D, Farid-Zahran M, Gutiérrez-Sánchez M, González-García MN, Guerrero AL, Porta-Etessam J (2020) Tension-type headache in the emergency department diagnosis and misdiagnosis: the TEDDi study. Sci Rep 10(1):2446PubMedPubMedCentralCrossRef
111.
112.
Błaszczyk B, Straburzyński M, Więckiewicz M, Budrewicz S, Niemiec P, Staszkiewicz M, Waliszewska-Prosół M (2023) Relationship between alcohol and primary headaches: a systematic review and meta-analysis. J Headache Pain 24(1):116PubMedPubMedCentralCrossRef
113.
Steiner TJ, Göbel H, Jensen R et al (2019) European headache federation and Lifting the Burden: the global campaign against headache. Headache service quality: the role of specialized headache centres within structured headache services, and suggested standards and criteria as centres of excellence. J Headache Pain 20(1):24PubMedPubMedCentralCrossRef
114.
García-Azorín D, Molina-Sánchez M, Gómez-Iglesias P, Delgado-Suárez C, García-Morales I, Kurtis-Urra M, Monje MHG (2022) Headache education and management in Cameroon: a healthcare provider study. Acta Neurol Belg 122(1):75–81PubMedCrossRef
115.
116.
Raffaelli B, Rubio-Beltrán E, Cho SJ, De Icco R, Labastida-Ramirez A, Onan D, Ornello R, Ruscheweyh R, Waliszewska-Prosół M, Messina R, Puledda F (2023) Health equity, care access and quality in headache - part 2. J Headache Pain 24(1):167PubMedPubMedCentralCrossRef
Metadata
Title
Health equity, care access and quality in headache – part 1
Authors
Claudio Tana
Bianca Raffaelli
Marcio Nattan Portes Souza
Elena Ruiz de la Torre
Daniel Gams Massi
Najib Kisani
David García-Azorín
Marta Waliszewska-Prosół
Publication date
01-12-2024
Publisher
Springer Milan
Published in
The Journal of Headache and Pain / Issue 1/2024
Print ISSN: 1129-2369
Electronic ISSN: 1129-2377
DOI
https://doi.org/10.1186/s10194-024-01712-7

Other articles of this Issue 1/2024

The Journal of Headache and Pain 1/2024 Go to the issue

Research

Trends and prescribing patterns of antimigraine medicines in nine major cities in China from 2018 to 2022: a retrospective prescription analysis

Methodology

The burden of headache disorders in North India: methodology, and validation of a Hindi version of the HARDSHIP questionnaire, for a community-based survey in Delhi and national capital territory region

Brief Report

Calcitonin gene-related peptide antagonists in pregnancy: a disproportionality analysis in VigiBase®

Research

Dynamic changes in glymphatic function in reversible cerebral vasoconstriction syndrome

Research

The burdens attributable to primary headache disorders in children and adolescents in Iran: estimates from a schools-based study

Research

Poor healthy lifestyle and life’s essential 8 are associated with higher risk of new-onset migraine: a prospective cohort study